RxDoctor Payments Data

Sachdev Somiah, MD

Psychiatry · Kingsport, TNNPI 1770521676

Payments from drug & device makers

$796in general payments, 2019–2025

Across 48 payments — averaging $16.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$211
  • Otsuka America Pharmaceutical, Inc.$148
  • Takeda Pharmaceuticals U.S.A., Inc.$78
  • Alkermes, Inc.$76
  • Vanda Pharmaceuticals Inc.$75
  • Lundbeck LLC$69
  • plus $140 from 4 others

What the payments were for

  • Food & beverage$796100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$796 in reported general payments places this provider in the 65th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$36,900
Medicare patients
108
Services billed
368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$117,114
TrintellixVortioxetine Hydrobromide43$27,199
ZubsolvBuprenorphine Hcl/Naloxone Hcl13$5,679
Aripiprazole125$5,474
Quetiapine Fumarate308$3,580
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl45$3,535
Bupropion XlBupropion Hcl81$3,299
Trazodone Hcl181$3,135
Buspirone Hcl225$2,951
Atomoxetine Hcl17$2,603
Vilazodone Hcl19$2,389
Venlafaxine Hcl ErVenlafaxine Hcl138$2,366
Desvenlafaxine Succinate ErDesvenlafaxine Succinate49$2,352
Duloxetine Hcl86$1,878
Lurasidone Hcl52$1,876

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$78$27,19943 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →